查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1729239

全球 CBD 消費者健康市場規模研究，按產品（醫療 OTC 產品、保健品）、配銷通路（線上商店、零售商店、零售藥局）和區域預測 2022-2032

Global CBD Consumer Health Market Size study, by Product (Medical OTC Products, Nutraceuticals), Distribution Channel (Online Stores, Retail Stores, Retail Pharmacies), and Regional Forecasts 2022-2032
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 285 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023 年全球 CBD 消費者健康市場價值約為 190.5 億美元，預計在 2024-2032 年預測期內將以超過 16.20% 的驚人複合年成長率成長。大麻二酚 (CBD) 消費者保健產品市場已迅速從小眾健康趨勢發展成為主流治療類別。 CBD 因其非精神活性益處而受到認可，它具有緩解多種疾病（從慢性疼痛和焦慮到失眠和發炎性疾病）的潛力，在全球範圍內獲得了廣泛的關注。消費者擴大轉向整體和植物衍生的替代品，這使得 CBD 成為現代自我照顧的基石。隨著主要市場（尤其是北美和歐洲）的監管框架逐漸放鬆，含有 CBD 的非處方藥和營養保健品的湧入正在重塑醫療保健零售格局。

CBD 消費者健康領域的爆炸性成長軌跡受到文化接受、立法進步和消費者對個人化健康的需求等因素的推動。越來越多的臨床證據支持大麻二酚在解決急性和慢性健康問題方面的安全性和有效性，這刺激了研發投資和產品創新。同時，CBD 產品製造商、製藥公司和零售商之間的策略合作夥伴關係正在加速高品質配方的可用性和可見性。然而，市場並非沒有摩擦。監管分類的模糊性、品質控制差異以及不一致的分銷協議繼續對更廣泛的採用和消費者信任構成挑戰，而這些問題正在透過 GMP 認證、第三方測試和更清晰的標籤標準慢慢得到緩解。

數位商務在擴大市場覆蓋範圍方面發揮關鍵作用。線上管道提供謹慎的訪問、廣泛的產品組合和教育資源，正在成為主要的分銷方式，尤其是在法律環境不斷變化的市場中。同時，由於消費者諮詢和醫生認可的增加，傳統零售業態（如藥局和以健康為中心的連鎖店）的 CBD 庫存正在復甦。這些多通路分銷模式使消費者更容易將 CBD 融入日常健康習慣。此外，隨著 CBD 在預防性醫療保健和生活方式管理中佔據一席之地，各公司正在實現產品組合多樣化，包括軟糖、酊劑、外用藥膏、膠囊和飲料等形式，每種形式都針對特定的健康結果進行客製化。

技術融合也正在催化創新。現在，人工智慧個人化工具正在幫助品牌根據健康目標和代謝狀況開發以消費者為中心的產品。此外，水溶性CBD製劑和奈米乳液技術的出現提高了生物利用度，增強了治療效果。新創公司和傳統企業都在投資永續採購、有機認證和清潔標籤品牌，以滿足挑剔的消費者的期望。隨著法律途徑不斷簡化，CBD融入主流醫療保健政策的前景（例如經醫學驗證的OTC應用的保險報銷）可能會引發另一波指數級成長。

從地區來看，受進步的立法、強大的零售基礎設施和高度的消費者意識的推動，北美繼續主導 CBD 消費者健康市場。歐洲緊隨其後，德國和英國等國家在監管清晰度和臨床接受度方面處於領先地位。受中產階級收入不斷擴大、城市化進程加快以及日本、韓國和澳洲等國家對天然保健產品需求日益成長的推動，亞太地區預計將在未來十年實現最快的成長。拉丁美洲和中東及非洲雖然目前還處於起步階段，但透過政府支持的試點計畫和消費者對天然藥物替代品日益成長的興趣，正穩步崛起。

目錄

第1章：全球 CBD 消費者健康市場執行摘要

  • 全球市場規模及預測（2022-2032）
  • 區域概要
  • 分段總結
    • 依產品（醫療非處方產品、保健食品）
    • 依配銷通路（網路商店、零售店、零售藥局）
  • 主要趨勢
  • 經濟衰退的影響
  • 分析師建議與結論

第2章：全球CBD消費者健康市場定義與研究假設

  • 研究目標
  • 市場定義
  • 研究假設
    • 包容與排斥
    • 限制
    • 供給側分析
      • 可用性
      • 基礎設施
      • 監管環境
      • 市場競爭
      • 經濟可行性（消費者觀點）
    • 需求面分析
      • 監理框架
      • 技術進步
      • 環境考慮
      • 消費者認知與接受度
  • 估算方法
  • 研究涵蓋的年份
  • 貨幣兌換率

第3章：全球CBD消費者健康市場動態

  • 市場促進因素
    • 對天然和植物療法的需求不斷成長
    • 主要市場逐步放寬監管
    • 數位商務和直接面對消費者模式的擴展
  • 市場挑戰
    • 監管模糊性和合規複雜性
    • 品質控制差異和第三方測試差距
    • 供應鏈限制與原料採購問題
  • 市場機會
    • 奈米乳液和水溶性CBD配方
    • 進入新興醫療保健和健康市場
    • 與製藥和零售連鎖店建立策略合作夥伴關係
    • 融入保險報銷的OTC項目

第4章：全球CBD消費者健康市場產業分析

  • 波特五力模型
    • 供應商的議價能力
    • 買家的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭對手
    • 波特模型的未來主義方法
    • 波特五力影響分析
  • PESTEL分析
    • 政治的
    • 經濟的
    • 社會的
    • 科技
    • 環境的
    • 合法的
  • 最佳投資機會
  • 最佳獲勝策略
  • 顛覆性趨勢
  • 產業專家觀點
  • 分析師建議與結論

第5章：全球 CBD 消費者健康市場規模與預測：按產品（2022-2032 年）

  • 細分儀表板
  • 2022 年和 2032 年醫療 OTC 產品收入趨勢分析
  • 2022 年和 2032 年營養保健品收入趨勢分析

第6章：全球 CBD 消費者健康市場規模與預測：按配銷通路（2022-2032 年）

  • 細分儀表板
  • 2022 年和 2032 年線上商店收入趨勢分析
  • 2022 年和 2032 年零售店收入趨勢分析
  • 2022 年和 2032 年零售藥局收入趨勢分析

第7章：全球 CBD 消費者健康市場規模與預測：按地區（2022-2032 年）

  • 北美市場
    • 美國市場
    • 加拿大市場
  • 歐洲市場
    • 英國市場
    • 德國市場
    • 法國市場
    • 西班牙市場
    • 義大利市場
    • 歐洲其他市場
  • 亞太市場
    • 中國市場
    • 印度市場
    • 日本市場
    • 澳洲市場
    • 韓國市場
    • 亞太其他市場
  • 拉丁美洲市場
    • 巴西市場
    • 墨西哥市場
    • 拉丁美洲其他市場
  • 中東和非洲市場
    • 沙烏地阿拉伯市場
    • 南非市場
    • 中東其他地區和非洲市場

第 8 章：競爭情報

  • 重點公司 SWOT 分析
    • Charlotte's Web Holdings, Inc.
    • CV Sciences, Inc.
    • Canopy Growth Corporation
  • 頂級市場策略
  • 公司簡介
    • Charlotte's Web Holdings, Inc.
      • 關鍵訊息
      • 概述
      • 財務（視數據可用性而定）
      • 產品概要
      • 市場策略
    • CV Sciences, Inc.
    • Canopy Growth Corporation
    • Aurora Cannabis Inc.
    • Elixinol Wellness Ltd
    • Green Roads CBD
    • Medterra CBD
    • Endoca
    • Irwin Naturals
    • Jazz Pharmaceuticals
    • Tilray Brands, Inc.
    • Isodiol International Inc.
    • CBD American Shaman
    • HempFusion Wellness Inc.
    • Gaia Botanicals, LLC

第9章：研究過程

  • 研究過程概述
    • 資料探勘
    • 分析
    • 市場評估
    • 驗證
    • 出版
  • 研究屬性
簡介目錄

Global CBD Consumer Health Market is valued at approximately USD 19.05 billion in 2023 and is anticipated to grow with an impressive CAGR of more than 16.20% over the forecast period 2024-2032. The market for cannabidiol (CBD) consumer health products has rapidly evolved from a niche wellness trend into a mainstream therapeutic category. Recognized for its non-psychoactive benefits, CBD has gained significant traction across the globe for its potential to alleviate a wide range of conditions-ranging from chronic pain and anxiety to insomnia and inflammatory disorders. The increasing shift of consumers toward holistic and plant-derived alternatives has transformed CBD into a cornerstone of modern self-care. As regulatory frameworks across key markets gradually loosen, particularly in North America and Europe, the influx of CBD-infused medical OTC products and nutraceuticals is reshaping the healthcare retail landscape.

The explosive growth trajectory of the CBD consumer health sector is being powered by a confluence of cultural acceptance, legislative progress, and consumer demand for personalized wellness. An expanding body of clinical evidence supporting the safety and efficacy of cannabidiol in addressing both acute and chronic health concerns has spurred R&D investments and product innovation. Meanwhile, strategic partnerships between CBD product manufacturers, pharmaceutical companies, and retailers are accelerating the availability and visibility of high-quality formulations. However, the market is not without friction. Ambiguities in regulatory classification, quality control disparities, and inconsistent distribution protocols continue to challenge broader adoption and consumer trust-issues that are slowly being mitigated through GMP certifications, third-party testing, and clearer labeling standards.

Digital commerce is playing a pivotal role in amplifying the market's reach. Online channels, which offer discreet access, wide product portfolios, and educational resources, are becoming the primary mode of distribution, especially in markets with evolving legal environments. In parallel, traditional retail formats-such as pharmacies and health-focused chains-are witnessing a resurgence in CBD stocking due to increased consumer inquiries and physician endorsements. These multi-channel distribution models are making it easier for consumers to incorporate CBD into their daily wellness routines. Moreover, as CBD finds its place in preventive healthcare and lifestyle management, companies are diversifying portfolios to include formats like gummies, tinctures, topical creams, capsules, and beverages, each tailored to specific health outcomes.

Innovation is also being catalyzed by technological integration. AI-enabled personalization tools are now helping brands develop consumer-centric products based on health goals and metabolic profiles. Furthermore, the emergence of water-soluble CBD formulations and nanoemulsion technologies has improved bioavailability, enhancing therapeutic efficacy. Startups and legacy players alike are investing in sustainable sourcing, organic certifications, and clean-label branding to meet the expectations of discerning consumers. As legal pathways continue to streamline, the prospect of CBD integration into mainstream healthcare policies-such as insurance reimbursement for medically validated OTC applications-could unlock yet another wave of exponential growth.

Regionally, North America continues to dominate the CBD consumer health market, driven by progressive legislation, strong retail infrastructure, and high consumer awareness. Europe is following closely, with countries like Germany and the UK leading in terms of regulatory clarity and clinical acceptance. Asia Pacific is poised for the fastest growth over the next decade, buoyed by expanding middle-class income, increasing urbanization, and a growing appetite for natural health products across countries like Japan, South Korea, and Australia. Latin America and the Middle East & Africa, while currently nascent, are steadily emerging through government-backed pilot programs and rising consumer interest in natural medicine alternatives.

Major market player included in this report are:

  • Charlotte's Web Holdings, Inc.
  • CV Sciences, Inc.
  • Elixinol Wellness Ltd
  • Canopy Growth Corporation
  • Aurora Cannabis Inc.
  • Green Roads CBD
  • Medterra CBD
  • Endoca
  • Irwin Naturals
  • Jazz Pharmaceuticals
  • Tilray Brands, Inc.
  • Isodiol International Inc.
  • CBD American Shaman
  • HempFusion Wellness Inc.
  • Gaia Botanicals, LLC

The detailed segments and sub-segment of the market are explained below:

By Product

  • Medical OTC Products
  • Nutraceuticals

By Distribution Channel

  • Online Stores
  • Retail Stores
  • Retail Pharmacies

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with country-level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global CBD Consumer Health Market Executive Summary

  • 1.1. Global Market Size & Forecast (2022-2032)
  • 1.2. Regional Summary
  • 1.3. Segmental Summary
    • 1.3.1. By Product (Medical OTC Products, Nutraceuticals)
    • 1.3.2. By Distribution Channel (Online Stores, Retail Stores, Retail Pharmacies)
  • 1.4. Key Trends
  • 1.5. Recession Impact
  • 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global CBD Consumer Health Market Definition and Research Assumptions

  • 2.1. Research Objective
  • 2.2. Market Definition
  • 2.3. Research Assumptions
    • 2.3.1. Inclusion & Exclusion
    • 2.3.2. Limitations
    • 2.3.3. Supply Side Analysis
      • 2.3.3.1. Availability
      • 2.3.3.2. Infrastructure
      • 2.3.3.3. Regulatory Environment
      • 2.3.3.4. Market Competition
      • 2.3.3.5. Economic Viability (Consumer Perspective)
    • 2.3.4. Demand Side Analysis
      • 2.3.4.1. Regulatory Frameworks
      • 2.3.4.2. Technological Advancements
      • 2.3.4.3. Environmental Considerations
      • 2.3.4.4. Consumer Awareness & Acceptance
  • 2.4. Estimation Methodology
  • 2.5. Years Considered for the Study
  • 2.6. Currency Conversion Rates

Chapter 3. Global CBD Consumer Health Market Dynamics

  • 3.1. Market Drivers
    • 3.1.1. Growing Demand for Natural & Plant-Derived Remedies
    • 3.1.2. Progressive Regulatory Relaxation in Key Markets
    • 3.1.3. Expansion of Digital Commerce & Direct-to-Consumer Models
  • 3.2. Market Challenges
    • 3.2.1. Regulatory Ambiguity & Compliance Complexity
    • 3.2.2. Quality Control Disparities & Third-Party Testing Gaps
    • 3.2.3. Supply-Chain Constraints and Ingredient Sourcing Issues
  • 3.3. Market Opportunities
    • 3.3.1. Nanoemulsion & Water-Soluble CBD Formulations
    • 3.3.2. Entry into Emerging Healthcare & Wellness Markets
    • 3.3.3. Strategic Partnerships with Pharma and Retail Chains
    • 3.3.4. Integration into Insurance-Reimbursed OTC Programs

Chapter 4. Global CBD Consumer Health Market Industry Analysis

  • 4.1. Porter's Five Forces Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's Model
    • 4.1.7. Porter's Five Forces Impact Analysis
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economic
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top Investment Opportunities
  • 4.4. Top Winning Strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspectives
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global CBD Consumer Health Market Size & Forecasts by Product (2022-2032)

  • 5.1. Segment Dashboard
  • 5.2. Medical OTC Products Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 5.3. Nutraceuticals Revenue Trend Analysis, 2022 & 2032 (USD Billion)

Chapter 6. Global CBD Consumer Health Market Size & Forecasts by Distribution Channel (2022-2032)

  • 6.1. Segment Dashboard
  • 6.2. Online Stores Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 6.3. Retail Stores Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 6.4. Retail Pharmacies Revenue Trend Analysis, 2022 & 2032 (USD Billion)

Chapter 7. Global CBD Consumer Health Market Size & Forecasts by Region (2022-2032)

  • 7.1. North America Market
    • 7.1.1. U.S. Market
    • 7.1.2. Canada Market
  • 7.2. Europe Market
    • 7.2.1. UK Market
    • 7.2.2. Germany Market
    • 7.2.3. France Market
    • 7.2.4. Spain Market
    • 7.2.5. Italy Market
    • 7.2.6. Rest of Europe Market
  • 7.3. Asia Pacific Market
    • 7.3.1. China Market
    • 7.3.2. India Market
    • 7.3.3. Japan Market
    • 7.3.4. Australia Market
    • 7.3.5. South Korea Market
    • 7.3.6. Rest of Asia Pacific Market
  • 7.4. Latin America Market
    • 7.4.1. Brazil Market
    • 7.4.2. Mexico Market
    • 7.4.3. Rest of Latin America Market
  • 7.5. Middle East & Africa Market
    • 7.5.1. Saudi Arabia Market
    • 7.5.2. South Africa Market
    • 7.5.3. Rest of Middle East & Africa Market

Chapter 8. Competitive Intelligence

  • 8.1. Key Company SWOT Analysis
    • 8.1.1. Charlotte's Web Holdings, Inc.
    • 8.1.2. CV Sciences, Inc.
    • 8.1.3. Canopy Growth Corporation
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. Charlotte's Web Holdings, Inc.
      • 8.3.1.1. Key Information
      • 8.3.1.2. Overview
      • 8.3.1.3. Financial (Subject to Data Availability)
      • 8.3.1.4. Product Summary
      • 8.3.1.5. Market Strategies
    • 8.3.2. CV Sciences, Inc.
    • 8.3.3. Canopy Growth Corporation
    • 8.3.4. Aurora Cannabis Inc.
    • 8.3.5. Elixinol Wellness Ltd
    • 8.3.6. Green Roads CBD
    • 8.3.7. Medterra CBD
    • 8.3.8. Endoca
    • 8.3.9. Irwin Naturals
    • 8.3.10. Jazz Pharmaceuticals
    • 8.3.11. Tilray Brands, Inc.
    • 8.3.12. Isodiol International Inc.
    • 8.3.13. CBD American Shaman
    • 8.3.14. HempFusion Wellness Inc.
    • 8.3.15. Gaia Botanicals, LLC

Chapter 9. Research Process

  • 9.1. Research Process Overview
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes